GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
4,937
Funds Holding Change
+94
Funds Holding Growth
+2%
Value
$1.28T
Holding in Top 10
850
Top 10 Change
+146
Top 10 Growth
+21%
Value Growth
+17%
New
294
Increased
2,416
Reduced
1,904
Closed
134
Capital Inflow
$42.8B
Capital Outflow
$39.6B
Net Capital Flow
+$3.25B
Capital Flow Change
+$574M
Calls
$18.7B
Puts
$20.2B
Net Calls
-$1.48B
Put/Call Ratio
1.08